Total
0
Shares
Lobe Sciences (CSE:LOBE) to present at the Benzinga Global Small Cap Conference
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Lobe Sciences (LOBE) to present at the Benzinga Global Small Cap Conference
  • Philip Young, CEO and Director will be presenting on Thursday, May 13 at 12:25 pm ET
  • The Benzinga Global Small Cap Conference bridges the gap between Small Cap companies, investors, and traders
  • Lobe is a life sciences company focused on psychedelic medicines
  • Lobe Sciences Ltd. (LOBE) is down 4 per cent and is trading at C$0.12 at 1:59 pm ET

Lobe Sciences Ltd. (LOBE) will be presenting at the Benzinga Global Small-Cap Conference taking place on May 13-14, 2021.

Philip Young, CEO and Director will be presenting on Thursday, May 13 at 12:25 pm ET.

Philip Young, CEO and Director of Lobe, stated,

"We look forward to discussing the latest developments and opportunities ahead of us as we continue on our mission to improve the health of people globally by improving the human condition."

To find out more information and/or to register for a free spectator pass for the conference, Lobe suggests heading to Benzinga's website. 

The Benzinga Global Small Cap Conference bridges the gap between Small Cap companies, investors, and traders.

 It also suggests–if interested in learning more about small cap investing with clearly defined educational modules–to look at a curated group of smallcap investment opportunities and connect with the global small cap audience in an intimate, virtual setting.

Lobe is a life sciences company focused on psychedelic medicines.

Lobe, through collaborations with industry-leading partners, is engaged in drug research and development using psychedelic compounds and the development of innovative devices and delivery mechanisms to improve mental health and wellness.

Lobe Sciences Ltd. (LOBE) is down 4 per cent and is trading at C$0.12 at 1:59 pm ET.

More From The Market Herald
Levitee Labs - CEO, Pouya Farmand. - The Market Herald Canada

" Levitee Labs (CSE:LVT) announces DTC eligibility

Common shares of Levitee Labs (LVT) are now eligible to be electronically cleared and settled through the DTC.
Mindset Pharma (CSE:MSET) announces inclusion in the AdvisorShares Psychedelics Exchange Traded Fund

" Mindset Pharma (CSE:MSET) announces inclusion in the AdvisorShares Psychedelics Exchange Traded Fund

Mindset Pharma (MSET) has announced its inclusion in the NYSE-traded AdvisorShares Psychedelics ETF.
Clearmind Medicine (CSE:CMND) announces closing of private placement

" Clearmind Medicine (CSE:CMND) partners with The Hebrew University

Clearmind Medicine (CMND) has established a research and development partnership with the Yissum Research Development Company.
Small Pharma - CEO, Peter Rands (third from left) and the Small Pharma team. - The Market Herald Canada

" Negev Capital doubles down on Small Pharma (TSXV:DMT)

Negev Capital, a psychedelic medical intervention fund, has doubled its investment in Small Pharma (DMT).